{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:07:28Z","timestamp":1787846848692,"version":"build-2784847793"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1U01DK123818-01"],"award-info":[{"award-number":["1U01DK123818-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["IBX004968 A"],"award-info":[{"award-number":["IBX004968 A"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK079337"],"award-info":[{"award-number":["P30 DK079337"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK110621"],"award-info":[{"award-number":["R01DK110621"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK128208"],"award-info":[{"award-number":["R01DK128208"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK12998"],"award-info":[{"award-number":["U01DK12998"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["1R01EB031813-01A1"],"award-info":[{"award-number":["1R01EB031813-01A1"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19TPA34850116"],"award-info":[{"award-number":["19TPA34850116"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["DK076169"],"award-info":[{"award-number":["DK076169"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["DK115255"],"award-info":[{"award-number":["DK115255"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["SCR_001415"],"award-info":[{"award-number":["SCR_001415"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1053\/j.akdh.2022.12.011","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:21:50Z","timestamp":1677658910000},"page":"177-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Physiopathology of Phosphate Disorders"],"prefix":"10.1053","volume":"30","author":[{"given":"Ignacio","family":"Portales-Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6082-662X","authenticated-orcid":false,"given":"Timo","family":"Rieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1493-2338","authenticated-orcid":false,"given":"Sheikh B.","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-0072","authenticated-orcid":false,"given":"Sagar U.","family":"Nigwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-2459","authenticated-orcid":false,"given":"Javier A.","family":"Neyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1053\/j.akdh.2022.12.011_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.EJ22-0239","article-title":"Advances in understanding of phosphate homeostasis and related disorders","volume":"69","author":"Michigami","year":"2022","journal-title":"Endocr J"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.011_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/hdi.12010","article-title":"Phosphorus, phosphorous, and phosphate","volume":"17","author":"Iheagwara","year":"2013","journal-title":"Hemodial Int"},{"key":"10.1053\/j.akdh.2022.12.011_bib3","series-title":"Serum inorganic phosphorus. Clinical methods: The History, Physical, and Laboratory Examinations","author":"Bansal","year":"1990"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.011_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.beem.2018.06.004","article-title":"Phosphate homeostasis disorders","volume":"32","author":"Christov","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.011_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00467-014-2759-x","article-title":"Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?","volume":"30","author":"Lee","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"suppl 78","key":"10.1053\/j.akdh.2022.12.011_bib7","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1046\/j.1523-1755.2001.59780190.x","article-title":"Phosphate removal and hemodialysis conditions","volume":"59","author":"Pohlmeier","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2022.12.011_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.011_bib9","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.011_bib10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jbmr.2523","article-title":"Intestinal depletion of NaPi-IIb\/Slc34a2 in mice: renal and hormonal adaptation","volume":"30","author":"Hernando","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.011_bib11","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/jps.22614","article-title":"Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies","volume":"100","author":"Miyamoto","year":"2011","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib12","doi-asserted-by":"crossref","first-page":"G496","DOI":"10.1152\/ajpgi.00167.2004","article-title":"Regulation of Intestinal Phosphate Transport I. Segmental expression and adaptation to low-Pi diet of the type IIb Na+-Pi cotransporter in mouse small intestine","volume":"288","author":"Radanovic","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","article-title":"Intestinal phosphate transport","volume":"18","author":"Sabbagh","year":"2011","journal-title":"Adv Chron Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib14","doi-asserted-by":"crossref","first-page":"C429","DOI":"10.1152\/ajpcell.00331.2004","article-title":"Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor-and 1\u03b1OHase-deficient mice","volume":"288","author":"Capuano","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib15","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1152\/ajprenal.00375.2003","article-title":"Intestinal Na-Pi cotransporter adaptation to dietary Pi content in vitamin D receptor null mice","volume":"287","author":"Segawa","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.011_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbrc.2009.02.067","article-title":"Targeted deletion of the tybe IIb Na+-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality","volume":"381","author":"Shibasaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib17","doi-asserted-by":"crossref","first-page":"G233","DOI":"10.1152\/ajpgi.00032.2019","article-title":"Paracellular transport of phosphate along the intestine","volume":"317","author":"Kn\u00f6pfel","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.akdh.2022.12.011_bib18","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1073\/pnas.220394197","article-title":"A dibasic motif involved in parathyroid hormone-induced down-regulation of the type IIa NaPi cotransporter","volume":"(23),","author":"Karim-Jimenez","year":"2000","journal-title":"Proc Natl Acad Sci U S A, 97"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1359\/jbmr.2000.15.6.1033","article-title":"Nuclear localization of the type 1 PTH\/PTHrP receptor in rat tissues","volume":"15","author":"Watson","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib20","doi-asserted-by":"crossref","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","article-title":"Phosphate transporters: a tale of two solute carrier families","volume":"293","author":"Virkki","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BST20211005","article-title":"Npt2a as a target for treating hyperphosphatemia","volume":"50","author":"Thomas","year":"2022","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.011_bib22","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","article-title":"Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities","volume":"95","author":"Beck","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib23","doi-asserted-by":"crossref","first-page":"F671","DOI":"10.1152\/ajprenal.00156.2009","article-title":"Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development","volume":"297","author":"Segawa","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"issue":"13","key":"10.1053\/j.akdh.2022.12.011_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","article-title":"Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium\u2013phosphate cotransporter","volume":"347","author":"Pri\u00e9","year":"2002","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.011_bib25","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1359\/jbmr.2003.18.12.2135","article-title":"Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa","volume":"18","author":"Virkki","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.011_bib26","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/sj.ki.5000437","article-title":"NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak","volume":"69","author":"Lapointe","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.011_bib27","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1210\/jc.2005-2840","article-title":"Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1053\/j.akdh.2022.12.011_bib28","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1042\/CS20201453","article-title":"Klotho and calciprotein particles as therapeutic targets against accelerated ageing","volume":"135","author":"Kuro-o","year":"2021","journal-title":"Clin Sci"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.011_bib29","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-14-178","article-title":"Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005\u20132010","volume":"14","author":"Wojcicki","year":"2013","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.011_bib31","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","article-title":"Hypophosphatemia: an update on its etiology and treatment","volume":"118","author":"Gaasbeek","year":"2005","journal-title":"Am J Med"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.011_bib32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2215\/CJN.12410921","article-title":"Association of phosphate-containing versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy","volume":"17","author":"Bastin","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib33","doi-asserted-by":"crossref","first-page":"e13526","DOI":"10.1111\/apha.13526","article-title":"Intestinal epithelial ablation of Pit-2\/Slc20a2 in mice leads to sustained elevation of vitamin D3 upon dietary restriction of phosphate","volume":"230","author":"Pastor-Arroyo","year":"2020","journal-title":"Acta Physiol"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.011_bib34","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1, 25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib35","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI119289","article-title":"Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content","volume":"99","author":"L\u00f6tscher","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy","volume":"471","author":"Bergwitz","year":"2019","journal-title":"Pfl\u00fcgers Arch"},{"key":"10.1053\/j.akdh.2022.12.011_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bone.2013.11.008","article-title":"A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient","volume":"59","author":"Chi","year":"2014","journal-title":"Bone"},{"key":"10.1053\/j.akdh.2022.12.011_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2016.12.001","article-title":"Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3\/NPT2c","volume":"97","author":"Dhir","year":"2017","journal-title":"Bone"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib39","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1210\/clinem\/dgab635","article-title":"Acute effects of an inorganic phosphorus additive on mineral metabolism and cardiometabolic risk factors in healthy subjects","volume":"107","author":"Volk","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib40","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"White","year":"2000","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.011_bib42","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1053\/j.akdh.2022.12.011_bib43","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X\u2013linked hypophosphatemic rickets","volume":"11","author":"Francis","year":"1995","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pag\u00e8s","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/clinem\/dgab729","article-title":"Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia","volume":"107","author":"Linglart","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib47","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bone.2012.11.012","article-title":"Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood","volume":"52","author":"Seton","year":"2013","journal-title":"Bone"},{"key":"10.1053\/j.akdh.2022.12.011_bib49","doi-asserted-by":"crossref","first-page":"116202","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer","year":"2022","journal-title":"Bone"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.011_bib51","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.011_bib52","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/jcm9113587","article-title":"A pooled analysis of serum phosphate measurements and potential hypophosphataemia events in 45 interventional trials with ferric carboxymaltose","volume":"9","author":"Rosano","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.011_bib53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.011_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2021.12.015","article-title":"Zoledronic acid\u2013associated Fanconi syndrome in patients with cancer","volume":"80","author":"Portales-Castillo","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib55","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1523-1755.2001.060002694.x","article-title":"Glycosphingolipids modulate renal phosphate transport in potassium deficiency","volume":"60","author":"Zajicek","year":"2001","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.011_bib56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/bjaed\/mkw033","article-title":"Phosphate homeostasis in critical care","volume":"16","author":"Wadsworth","year":"2016","journal-title":"BJA Educ"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.011_bib57","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.clnu.2020.12.017","article-title":"Prevalence of Hypophosphatemia in the ICU\u2013results of an international one-day point prevalence survey","volume":"40","author":"Berger","year":"2021","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.011_bib58","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archinte.1980.00330170029018","article-title":"Hypophosphatemia in the alcoholic","volume":"140","author":"Knochel","year":"1980","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib60","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2215\/CJN.01660309","article-title":"Phosphate levels and cardiovascular disease in the general population","volume":"4","author":"Foley","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","article-title":"Serum phosphorus levels associate with coronary atherosclerosis in young adults","volume":"20","author":"Foley","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.011_bib62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib63","first-page":"929","article-title":"Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus","volume":"88","author":"Fass","year":"1993","journal-title":"Am J Gastroenterol"},{"issue":"25","key":"10.1053\/j.akdh.2022.12.011_bib64","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMra0904186","article-title":"Genetic disorders of renal phosphate transport","volume":"362","author":"Pri\u00e9","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM198107163050301","article-title":"The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure: interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1, 25-dihydroxycholecalciferol","volume":"305","author":"Llach","year":"1981","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.011_bib66","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1681\/ASN.2013101102","article-title":"Renal phosphate wasting in the absence of adenylyl cyclase 6","volume":"25","author":"Fenton","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/en.2015-1639","article-title":"Ablation of the stimulatory G protein \u03b1-subunit in renal proximal tubules leads to parathyroid hormone-resistance with increased renal Cyp24a1 mRNA abundance and reduced serum 1, 25-dihydroxyvitamin D","volume":"157","author":"Zhu","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib68","first-page":"1","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib69","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/clinem\/dgab060","article-title":"Molecular definition of pseudohypoparathyroidism variants","volume":"106","author":"J\u00fcppner","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.akdh.2022.12.011_bib70","doi-asserted-by":"crossref","first-page":"928284","DOI":"10.3389\/fendo.2022.928284","article-title":"Case Report: Inactivating PTH\/PTHrP signaling disorder type 1 presenting with PTH resistance","volume":"13","author":"Demaret","year":"2022","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.011_bib71","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/gbb.12308","article-title":"Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation","volume":"15","author":"Guerreiro","year":"2016","journal-title":"Gene Brain Behav"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000508985","article-title":"Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an updated practical tool for physicians and patients","volume":"93","author":"Mantovani","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pag\u00e8s","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib74","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/en.2008-0877","article-title":"Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression","volume":"150","author":"Ichikawa","year":"2009","journal-title":"Endocrinology"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.011_bib75","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.011_bib76","doi-asserted-by":"crossref","first-page":"e123817","DOI":"10.1172\/jci.insight.123817","article-title":"Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD","volume":"4","author":"Clinkenbeard","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfu291","article-title":"The demonstration of \u03b1Klotho deficiency in human chronic kidney disease with a novel synthetic antibody","volume":"30","author":"Barker","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.011_bib78","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2215\/CJN.04250419","article-title":"Short-term effects of very-low-phosphate and low-phosphate diets on fibroblast growth factor 23 in hemodialysis patients: a randomized crossover trial","volume":"14","author":"Tsai","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000245640","article-title":"Phosphate elimination in modalities of hemodialysis and peritoneal dialysis","volume":"29","author":"Kuhlmann","year":"2010","journal-title":"Blood Purif"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.011_bib80","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2016.03.039","article-title":"Phosphate\u2014a poison for humans?","volume":"90","author":"Komaba","year":"2016","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.011_bib81","doi-asserted-by":"crossref","first-page":"e74996","DOI":"10.1371\/journal.pone.0074996","article-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","volume":"8","author":"McGovern","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib82","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.011_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) foreword","volume":"7","author":"Wheeler","year":"2017","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib84","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.011_bib85","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.34067\/KID.0002002021","article-title":"Safety and efficacy of Tenapanor for Long-term serum phosphate control in maintenance dialysis: a 52-week randomized Phase 3 trial (PHREEDOM)","volume":"2","author":"Block","year":"2021","journal-title":"Kidney360"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.011_bib86","doi-asserted-by":"crossref","first-page":"e13756","DOI":"10.1111\/apha.13756","article-title":"Enhanced phosphate absorption in intestinal epithelial cell-specific NHE3 knockout mice","volume":"234","author":"Xue","year":"2022","journal-title":"Acta Physiol"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.011_bib87","first-page":"1465","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)","author":"Ruospo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib88","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.xkme.2021.07.003","article-title":"Phosphate absorption and hyperphosphatemia management in kidney disease: a physiology-based review","volume":"3","author":"Fishbane","year":"2021","journal-title":"Kidney Med"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.011_bib89","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/j.ajkd.2020.10.008","article-title":"Design and rationale of HiLo: a pragmatic, randomized trial of phosphate management for patients receiving maintenance hemodialysis","volume":"77","author":"Edmonston","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.011_bib90","doi-asserted-by":"crossref","first-page":"F541","DOI":"10.1152\/ajprenal.00146.2020","article-title":"PF-06869206 is a selective inhibitor of renal Pi transport: evidence from in vitro and in vivo studies","volume":"319","author":"Thomas","year":"2020","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.011_bib91","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1681\/ASN.2018121250","article-title":"Pharmacological Npt2a inhibition causes phosphaturia and reduces plasma phosphate in mice with normal and reduced kidney function","volume":"30","author":"Thomas","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.011_bib92","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1172\/JCI135665","article-title":"Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion","volume":"130","author":"Clerin","year":"2020","journal-title":"J Clin Invest"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813922000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813922000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:11:53Z","timestamp":1762650713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813922000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2949813922000362"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2022.12.011","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiopathology of Phosphate Disorders","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2022.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}